218 related articles for article (PubMed ID: 29530581)
1. A systematic approach to the formulation of anti-onychomycotic nail patches.
Rizi K; Mohammed IK; Xu K; Kinloch AJ; Charalambides MN; Murdan S
Eur J Pharm Biopharm; 2018 Jun; 127():355-365. PubMed ID: 29530581
[TBL] [Abstract][Full Text] [Related]
2. A drug-in-adhesive anti-onychomycotic nail patch: Influence of drug and adhesive nature on drug release, ungual permeation, in vivo residence in human and anti-fungal efficacy.
Rizi K; Xu K; Begum T; Faull J; Bhakta S; Murdan S
Int J Pharm; 2022 Feb; 614():121437. PubMed ID: 34973408
[TBL] [Abstract][Full Text] [Related]
3. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
Murthy SN; Vaka SR; Sammeta SM; Nair AB
J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
[TBL] [Abstract][Full Text] [Related]
4. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Bhatt V; Pillai R
J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
[TBL] [Abstract][Full Text] [Related]
5. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
6. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
[TBL] [Abstract][Full Text] [Related]
7. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
Elsherif NI; Shamma RN; Abdelbary G
AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
[TBL] [Abstract][Full Text] [Related]
8. Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders.
Brown M; Turner R; Wevrett SR
Expert Opin Drug Deliv; 2018 Oct; 15(10):983-989. PubMed ID: 30173543
[TBL] [Abstract][Full Text] [Related]
9. Influence of human nail etching for the assessment of topical onychomycosis therapies.
Repka MA; Mididoddi PK; Stodghill SP
Int J Pharm; 2004 Sep; 282(1-2):95-106. PubMed ID: 15336385
[TBL] [Abstract][Full Text] [Related]
10. Ungual and transungual drug delivery.
Shivakumar HN; Juluri A; Desai BG; Murthy SN
Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
[TBL] [Abstract][Full Text] [Related]
11. Drug delivery to the nail following topical application.
Murdan S
Int J Pharm; 2002 Apr; 236(1-2):1-26. PubMed ID: 11891066
[TBL] [Abstract][Full Text] [Related]
12. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
[TBL] [Abstract][Full Text] [Related]
13. Insights into drug delivery across the nail plate barrier.
Saner MV; Kulkarni AD; Pardeshi CV
J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
[TBL] [Abstract][Full Text] [Related]
14. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
15. Iontophoretic drug delivery across the nail.
Delgado-Charro MB
Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
[TBL] [Abstract][Full Text] [Related]
16. UV-curable gel formulations: Potential drug carriers for the topical treatment of nail diseases.
Kerai LV; Hilton S; Murdan S
Int J Pharm; 2015 Aug; 492(1-2):177-90. PubMed ID: 26187167
[TBL] [Abstract][Full Text] [Related]
17. Transungual delivery of ketoconazole using novel lacquer formulation.
Hafeez F; Hui X; Chiang A; Hornby S; Maibach H
Int J Pharm; 2013 Nov; 456(2):357-61. PubMed ID: 24029171
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the nail permeability of topically applied drugs.
Murdan S
Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
[TBL] [Abstract][Full Text] [Related]
19. A pharmaceutics perspective on drug delivery to the nail: recent advances and challenges.
Delgado-Charro MB
Ther Deliv; 2015 Jul; 6(7):773-5. PubMed ID: 26228770
[No Abstract] [Full Text] [Related]
20. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
